Michelle Wells

Senior Director Regulatory Affairs @Corcept Therapeutics

Menlo Park, CA, US
EMAILS
m•••••@corcept.com
MOBILE NUMBERS
+19•••••••52

Signup · Get unlimited contacts

WORK HISTORY

Oct 2022 — Present

Senior Director Regulatory Affairs @Corcept Therapeutics

View department →

Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess…

EDUCATION

N/A

Napa Valley College

AA, Natural Science

2008 — 2008

Northwestern University - Kellogg School of Management

Regulatory Affairs Professional Society Certificate, Regulatory Affairs Executive Development

2004

Arizona State University

BS, Cell Biology & Physiology, Pre-Law Minor

2016

Arizona State University

Masters of Science, Clinical Research Management (Regulatory Science)

SKILLS

BiotechnologyTopical MedicationR&DLifesciencesDesign ControlLife SciencesStrategyValidationQuality SystemNew Drug Application (Nda)Medical DevicesU.s. Food and Drug Administration (Fda)AndaCapaClinical TrialsNdaCorrective and Preventive Action (Capa)Iso 13485Regulatory AffairsPharmaceutical IndustryPharmaceuticsResearch and Development (R&D)Quality AuditingRegulatory SubmissionsRegulatory RequirementsFdaGmp

ABOUT MICHELLE WELLS

Regulatory Affairs Certified (RAC) professional with extensive experience in drugs…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.